Randomized trial examines lipid metabolism's impact on chronic kidney disease progression, suggesting therapy targets for metabolic homeostasis.
Key Points
This research aims to understand how energy metabolism in the kidneys influences chronic kidney disease progression. It explores the roles of specific metabolic regulators in maintaining kidney function.
Focus on lipid metabolism in proximal kidney tubules
Examine energy sensing via AMPK and PPARα in CKD models
Analyze effects of uremic metabolites on AMPK activity
Identified decreased AMPK activity in CKD, linked to impaired energy responses
Found PPARα crucial for influencing proximal tubule size and compensatory hypertrophy
Revealed ULK1's role in enhancing AMP sensitivity of AMPK through phosphorylation